Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol.
The effects of small oral doses (1-2 microgram/day) of 1alpha-hydroxycholecalciferol, given for 1 to 2 years, have been examined in four nondialysed adolescents with chronic renal failure and bone disease. Treatment increased calcium retention and plasma calcium, and decreased plasma levels of alkal...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
1977
|
| _version_ | 1826295765258993664 |
|---|---|
| author | Kanis, J Henderson, R Heynen, G Ledingham, J Russell, R Smith, R Walton, R |
| author_facet | Kanis, J Henderson, R Heynen, G Ledingham, J Russell, R Smith, R Walton, R |
| author_sort | Kanis, J |
| collection | OXFORD |
| description | The effects of small oral doses (1-2 microgram/day) of 1alpha-hydroxycholecalciferol, given for 1 to 2 years, have been examined in four nondialysed adolescents with chronic renal failure and bone disease. Treatment increased calcium retention and plasma calcium, and decreased plasma levels of alkaline phosphatase, hydroxyproline, and immunoreactive parathyroid hormone. X-ray abnormalities of bone regressed, and 2 patients underwent successful surgical correction of knock-knees; bone histology in these 2 was normal at the time of operation. 2 patients developed hypercalcaemia which promptly reversed when 1alpha-hydroxycholecalciferol was withdrawn. In one patient treatment was initially successful, but later there was biochemical, radiographic, and histological evidence of relapse. Long-term treatment of such patients with 1alpha-hydroxycholecalciferol may be effective and facilitate the surgical correction of deformities, but this is not invariable. Toxic effects are similar to those of vitamin D itself, but are more readily reversible. |
| first_indexed | 2024-03-07T04:06:05Z |
| format | Journal article |
| id | oxford-uuid:c633f092-d52b-43a6-9dc0-caf04a2fdbe5 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T04:06:05Z |
| publishDate | 1977 |
| record_format | dspace |
| spelling | oxford-uuid:c633f092-d52b-43a6-9dc0-caf04a2fdbe52022-03-27T06:36:29ZRenal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:c633f092-d52b-43a6-9dc0-caf04a2fdbe5EnglishSymplectic Elements at Oxford1977Kanis, JHenderson, RHeynen, GLedingham, JRussell, RSmith, RWalton, RThe effects of small oral doses (1-2 microgram/day) of 1alpha-hydroxycholecalciferol, given for 1 to 2 years, have been examined in four nondialysed adolescents with chronic renal failure and bone disease. Treatment increased calcium retention and plasma calcium, and decreased plasma levels of alkaline phosphatase, hydroxyproline, and immunoreactive parathyroid hormone. X-ray abnormalities of bone regressed, and 2 patients underwent successful surgical correction of knock-knees; bone histology in these 2 was normal at the time of operation. 2 patients developed hypercalcaemia which promptly reversed when 1alpha-hydroxycholecalciferol was withdrawn. In one patient treatment was initially successful, but later there was biochemical, radiographic, and histological evidence of relapse. Long-term treatment of such patients with 1alpha-hydroxycholecalciferol may be effective and facilitate the surgical correction of deformities, but this is not invariable. Toxic effects are similar to those of vitamin D itself, but are more readily reversible. |
| spellingShingle | Kanis, J Henderson, R Heynen, G Ledingham, J Russell, R Smith, R Walton, R Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol. |
| title | Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol. |
| title_full | Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol. |
| title_fullStr | Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol. |
| title_full_unstemmed | Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol. |
| title_short | Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol. |
| title_sort | renal osteodystrophy in nondialysed adolescents long term treatment with 1alpha hydroxycholecalciferol |
| work_keys_str_mv | AT kanisj renalosteodystrophyinnondialysedadolescentslongtermtreatmentwith1alphahydroxycholecalciferol AT hendersonr renalosteodystrophyinnondialysedadolescentslongtermtreatmentwith1alphahydroxycholecalciferol AT heyneng renalosteodystrophyinnondialysedadolescentslongtermtreatmentwith1alphahydroxycholecalciferol AT ledinghamj renalosteodystrophyinnondialysedadolescentslongtermtreatmentwith1alphahydroxycholecalciferol AT russellr renalosteodystrophyinnondialysedadolescentslongtermtreatmentwith1alphahydroxycholecalciferol AT smithr renalosteodystrophyinnondialysedadolescentslongtermtreatmentwith1alphahydroxycholecalciferol AT waltonr renalosteodystrophyinnondialysedadolescentslongtermtreatmentwith1alphahydroxycholecalciferol |